Comparative Study Between Treatment With Cryotherapy Alone Versus Cryotherapy Plus Salicylic Acid Dressing for Planter Warts
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05588999 |
|
Recruitment Status :
Completed
First Posted : October 20, 2022
Last Update Posted : October 20, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Verrucae plantaris (plantar warts) are a frequent cutaneous lesion of the plantar portion of the foot caused by the human papillomavirus (HPV) (HPV).Although HPV is ubiquitous in our environment, cellular and humoral immune responses typically prevent it from spreading or eliminate it.
Warts can be painful and can lead to other difficulties, but there are some populations that are at a higher risk of getting HPV because they encounter the virus more frequently.
In addition to infecting other people, HPV can also spread to other locations in the area. While reducing exposure to risk factors can help prevent plantar wart infection, HPV's widespread nature makes it difficult for such efforts to be effective.
It has been shown in research that plantar warts can spread from person to person through just physical contact with the sores. Warts are more common in people with HPV because the virus disrupts the epithelial barrier. There are over a hundred different forms of the HPV virus, so even though some warts go away on their own after a few years, others may need medical attention.
Warts, according to a number of studies, are extremely common (affecting around 10% of the population) all over the world. More cases of HPV infection have been observed among people under the age of 30, compared to those beyond the age of 30. The estimated prevalence in the United States is between 10% and 20%. However, people with compromised immune systems and those who work with meat are disproportionately at risk.
The cancerous transformation of warts is quite rare. Even while verrucous carcinoma, a malignant form of wart development, is possible, it seldom spreads and only causes localised tissue loss.
Plantar warts are treated in a manner that takes into account the patient's symptoms, personal preferences, and financial situation. Even though there are several therapy options, none of them are particularly effective, and relapses are common after any treatment. As a result, the most accessible and least distressing treatment option should be prioritised.
Since salicylic acid can be used by the patient at home and does not require a doctor's prescription, it is often regarded a first-line therapy for the common wart. It can be as high as 70% effective in curing the disease. Other effective therapies for plantar warts include cryotherapy, retinoic acid, podophyllin, topical 5-fluorouracil, interferon, and imiquimod.
Salicylic acid, in conjunction with cryotherapy, has shown therapeutic efficacy in patients with only foot warts, according to a single prior study. Patients who were given cryotherapy in this trial had a 58% success rate at recovery, whereas those given salicylic acid had a 41% success rate. Hover, there is no discernible statistical difference.
The purpose of this study was to compare the effectiveness of cryotherapy alone against cryotherapy plus salicylic acid dressing for planter warts, keeping in mind the prevalence of treatment for plantar warts and the lack of a well-established, practically applicable, and reliably preventative method in our local population.
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Plantar Wart | Procedure: Cryotherapy Alone Combination Product: Cryotherapy plus Salicylic Acid | Phase 1 |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 70 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Treatment |
| Official Title: | Comparative Study Between Treatment With Cryotherapy Alone Versus Cryotherapy Plus Salicylic Acid Dressing for Planter Warts |
| Actual Study Start Date : | March 1, 2022 |
| Actual Primary Completion Date : | August 31, 2022 |
| Actual Study Completion Date : | August 31, 2022 |
| Arm | Intervention/treatment |
|---|---|
|
Active Comparator: Group A (Cryotherapy Alone)
Patients in this Group were subjected to Cryotherapy Alone with liquid nitrogen and received maximum of four treatments given two to three weeks apart
|
Procedure: Cryotherapy Alone
Patients in Group A were subjected to Cryotherapy Alone with liquid nitrogen and received maximum of four treatments given two to three weeks apart . The liquid nitrogen was applied with a spray or a probe |
|
Active Comparator: Group B (Cryotherapy plus Salicylic Acid)
Patients in this Group were subjected to cryotherapy plus salicylic acid for a maximum of eight weeks
|
Combination Product: Cryotherapy plus Salicylic Acid
Patients in Group B were subjected to cryotherapy plus with 50% salicylic acid to be properly applied for a maximum of eight weeks The liquid nitrogen was applied with a spray or a probe |
- effectiveness of cryotherapy with liquid nitrogen alone and cryotherapy with 50% salicylic acid for the treatment of plantar warts calculated through clinical improvement [ Time Frame: 12 weeks ]effectiveness assesed by %clinical improvement=(present % tissue distruction + baseline % tissue destruction)100
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 15 Years to 40 Years (Child, Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patients having aged between 15 to 40 years
- Patients diagnosed with planter warts on toe foot based on clinical and physical examination ,Patients with no history of treatment previously
- Patients of either gender
Exclusion Criteria:
- Patients with impaired healing (such as from diabetes or peripheral vascular disease)
- Immunosuppressed patients
- Patients taking immunosuppressant drugs (such as oral corticosteroids)
- Patients with neuropathy
- Patients receiving renal dialysis
- Patients unable to give informed consent
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05588999
| Pakistan | |
| Cmh Abbottabad | |
| Abbottābād, Khyber Pakhtunkhwa, Pakistan, 22020 | |
| Responsible Party: | Dr Mahboob Ali, principal investigator, Combined Military Hospital Abbottabad |
| ClinicalTrials.gov Identifier: | NCT05588999 |
| Other Study ID Numbers: |
CMHAtd-ETH-38-Derm-22 |
| First Posted: | October 20, 2022 Key Record Dates |
| Last Update Posted: | October 20, 2022 |
| Last Verified: | October 2022 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Planter Warts Cryotherapy Salicylic Acid |
|
Warts Papillomavirus Infections DNA Virus Infections Virus Diseases Infections Skin Diseases, Viral Tumor Virus Infections Skin Diseases, Infectious Skin Diseases Salicylic Acid Salicylates Anti-Infective Agents Antifungal Agents |
Keratolytic Agents Dermatologic Agents Anti-Inflammatory Agents, Non-Steroidal Analgesics, Non-Narcotic Analgesics Sensory System Agents Peripheral Nervous System Agents Physiological Effects of Drugs Anti-Inflammatory Agents Antirheumatic Agents Cyclooxygenase Inhibitors Enzyme Inhibitors Molecular Mechanisms of Pharmacological Action |

